Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering

Updated 05/14/2024

Status Terminated

Clinical Trial Summary

The study will evaluate the efficacy, safety and tolerability of prucalopride over 12 weeks of treatment in subjects aged 18 years and older with chronic non-cancer pain, suffering from opioid induced constipation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01117051
Study type	Interventional
Source	Takeda
Contact
Status	Terminated
Phase	Phase 3
Start date	May 19, 2010
Completion date	August 13, 2012

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT02813369` - Naloxegol Health Outcome Post Authorisation Safety Study
	Completed	`NCT01957046` - A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).	Phase 4
	Completed	`NCT01401985` - A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)	Phase 2
	Completed	`NCT00984334` - Naloxone SR Capsules in Patients With Opioid Induced Constipation	Phase 2
	Completed	`NCT01207427` - Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain	Phase 2
	Completed	`NCT01459926` - A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation	Phase 2
	Completed	`NCT03060512` - To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation	Phase 4
	Completed	`NCT01109511` - A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy	Phase 4
	Active, not recruiting	`NCT02813356` - Naloxegol US PMR CV Safety.
	Completed	`NCT01812733` - Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives	N/A
	Completed	`NCT01623609` - Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol	Phase 1
	Completed	`NCT02813148` - Naloxegol Drug Utilization Post Authorisation Safety Study
	Completed	`NCT01443403` - A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy	Phase 2
	Completed	`NCT03638440` - Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.